Add-on deep transcranial magnetic stimulation (dTMS) in patients with dysthymic disorder comorbid with alcohol use disorder: A comparison with standard treatment

World Journal of Biological Psychiatry

Volumn 16, Issue 1, 2015, Pages 66-73

  Girardi, Paolo ^a,b   Rapinesi, Chiara ^a,b   Chiarotti, Flavia ^c   Kotzalidis, Georgios D ^a   Piacentino, Daria ^a   Serata, Daniele ^a,b   Del Casale, Antonio ^a,b   Scatena, Paola ^b   Mascioli, Flavia ^b   Raccah, Ruggero N ^b   Brugnoli, Roberto ^a   Digiacomantonio, Vittorio ^b   Ferri, Vittoria Rachele ^a,b   Ferracuti, Stefano ^a   Zangen, Abraham ^d   Angeletti, Gloria ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Alcohology Service Villa Rosa Suore Hospitaliere of the Sacred Heart of Jesus ^*  (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Alcohol; Deep transcranial magnetic stimulation (dTMS); Depression; Dorsolateral pre frontal cortex (DLPFC); Dysthymia

Indexed keywords

DIAZEPAM; TRAZODONE;

ADULT; ALCOHOL USE DISORDER; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; CONTROLLED STUDY; DEEP TRANSCRANIAL MAGNETIC STIMULATION; DEPRESSION; DISEASE COURSE; DSM-IV-TR; DYSTHYMIA; EVOKED MUSCLE RESPONSE; FEMALE; FOLLOW UP; GLOBAL ASSESSMENT OF FUNCTIONING; HAMILTON DEPRESSION RATING SCALE; HUMAN; LEFT HEMISPHERE; MALE; OBSESSIVE COMPULSIVE DRINKING SCALE; OPEN STUDY; ORBITAL CORTEX; PREFRONTAL CORTEX; REMISSION; STANDARD; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; TREATMENT RESPONSE; WITHDRAWAL SYNDROME; AFFECT; AGED; ALCOHOL-RELATED DISORDERS; COMPARATIVE STUDY; DEPRESSIVE DISORDER, MAJOR; DYSTHYMIC DISORDER; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGICAL RATING SCALE;

ADULT; AFFECT; AGED; ALCOHOL-RELATED DISORDERS; COMORBIDITY; CRAVING; DEPRESSIVE DISORDER, MAJOR; DYSTHYMIC DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84920837981     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2014.925583     Document Type: Article

References (45)

1. Alexander-Kaufman K, Cordwell S, Harper C, Matsumoto I. 2007. A proteome analysis of the dorsolateral prefrontal cortex in human alcoholic patients. Proteomics Clin Appl 1:62-72.
2. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
3. American Psychiatric Association. 2013. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington, VA: American Psychiatric Association.
4. Amiaz R, Levy D, Vainiger D, Grunhaus L, Zangen A. 2009. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction 104:653-660.
5. Anton RF, Moak DH, Latham P. 1995. The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res 19:92-99.
6. Anton RF, Moak DH, Latham PK. 1996. The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry 53:225-231, erratum 576.
7. Bosch OG, Wagner M, Jessen F, K ü hn KU, Joe A, Seifritz E, et al. 2013. Verbal memory deficits are correlated with prefrontal hypometabolism in 18 FDG PET of recreational MDMA users. PLoS One 8:e61234.
8. Chang CC, Yu SC, McQuoid DR, Messer DF, Taylor WD, Singh K, et al. 2011. Reduction of dorsolateral prefrontal cortex gray matter in late-life depression. Psychiatry Res 193:1-6.
9. Dragaševic N, Potrebi A, Damjanovi A, Stefanova E, Kosti VS. 2002. Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson's disease: an open study. Mov Disord 17:528-532.
10. Drummond DC. 2001. Theories of drug craving, ancient and modern. Addiction 96:33-46.
11. Endicott J, Spitzer RL, Fleiss JL. 1976. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33:766-771.
12. Enticott PG, Kennedy HA, Zangen A, Fitzgerald PB. 2011. Deep repetitive transcranial magnetic stimulation associated with improved social functioning in a young woman with an autism spectrum disorder. J ECT 27:41-43.
13. Ernst LH, Plichta MM, Dresler T, Zesewitz AK, Tupak SV, Haeussinger FB, et al. 2014. Prefrontal correlates of approach preferences for alcohol stimuli in alcohol dependence. Addict Biol. 19:497-508.
14. Feil J, Zangen A. 2010. Brain stimulation in the study and treatment of addiction. Neurosci Biobehav Rev 34:559-574.
15. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS. 1997. Structured Clinical Interview for DSM-IV Axis II Personality Disorders, (SCID-II). Washington, DC: American Psychiatric Press.
16. First MB, Spitzer RL, Gibbon M, Williams JBW. 2002. Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Patient Edition. New York, NY: Biometric Research, New York State Psychiatric Institute, A 1-46.
17. George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, et al. 2010. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry 67: 507-516.
18. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. 2004. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 61:807-816.
19. Guy W. 1976. ECDEU Assessment Manual of Psychopharmacology - Revised (DHEW Publ No ADM 76-338). Rockville, MD, USA: Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs; p. 218-222.
20. Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
21. Harel EV, Rabany L, Deutsch L, Bloch Y, Zangen A, Levkovitz Y. 2012. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: an 18-week continuation safety and feasibility study. World J Biol Psychiatry. 15(4):298-306.
22. Hasin DS, Stinson FS, Ogburn E, Grant BF. 2007. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 64:830-842.
23. Hecht D, Walsh V, Lavidor M. 2010. Transcranial direct current stimulation facilitates decision making in a probabilistic guessing task. J Neurosci 30:4241-4245.
24. Höppner J, Broese T, Wendler L, Berger C, Thome J. 2011. Repetitive transcranial magnetic stimulation (rTMS) for treatment of alcohol dependence. World J Biol Psychiatry 12(Suppl 1):57-62.
25. Huang ML, Luo BY, Hu JB, Wang SS, Zhou WH, Wei N, et al. 2012. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial. Aust NZ J Psychiatry 46:257-264.
26. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. 1994. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19.
27. Lang N, Hasan A, Sueske E, Paulus W, Nitsche MA. 2008. Cortical hypoexcitability in chronic smokers? A transcranial magnetic stimulation study. Neuropsychopharmacology 33:2517-2523.
28. Makris N, Oscar-Berman M, Jaffin SK, Hodge SM, Kennedy DN, Caviness VS, et al. 2008. Decreased volume of the brain reward system in alcoholism. Biol Psychiatry 64:192-202.
29. Mishra BR, Nizamie SH, Das B, Praharaj SK. 2010. Efficacy of repetitive transcranial magnetic stimulation in alcohol dependence: a sham-controlled study. Addiction 105:49-55.
30. Moreno-López L, Stamatakis EA, Fernández-Serrano MJ, Gómez-Río M, Rodríguez-Fernández A, Pérez-García M, et al. 2012. Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study. PLoS One 7:e39830.
31. O'Brien CP. 2005. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am J Psychiatry 162:1423-1431.
32. Oh DH, Son H, Hwang S, Kim SH. 2012. Neuropathological abnormalities of astrocytes, GABAergic neurons, and pyramidal neurons in the dorsolateral prefrontal cortices of patients with major depressive disorder. Eur Neuropsychopharmacol 22:330-338.
33. Olbrich HM, Valerius G, Paris C, Hagenbuch F, Ebert D, Juengling FD. 2006. Brain activation during craving for alcohol measured by positron emission tomography. Aust NZ J Psychiatry 40:171-178.
34. Park MS, Sohn JH, Suk JA, Kim SH, Sohn S, Sparacio R. 2007. Brain substrates of craving to alcohol cues in subjects with alcohol use disorder. Alcohol Alcohol 42:417-422.
35. Park SQ, Kahnt T, Beck A, Cohen MX, Dolan RJ, Wrase J, et al. 2010. Prefrontal cortex fails to learn from reward prediction errors in alcohol dependence. J Neurosci 30:7749-7753.
36. Politi E, Fauci E, Santoro A, Smeraldi E. 2008. Daily sessions of transcranial magnetic stimulation to the left prefrontal cortex gradually reduce cocaine craving. Am J Addict 17:345-346.
37. Rapinesi C, Kotzalidis GD, Serata D, del Casale A, Bersani FS, Solfanelli A, et al. 2013. Efficacy of add-on deep transcranial magnetic stimulation in comorbid alcohol dependence and dysthymic disorder: three case reports. Prim Care Companion CNS Disord 15(1) pii:PCC.12m01438; doi:10.4088/PCC.12m01438.
38. Ravindran AV, Smith A, Cameron C, Bhatla R, Cameron I, Georgescu TM, et al. 2009. Toward a functional neuroanatomy of dysthymia: a functional magnetic resonance imaging study. J Affect Disord 119:9-15.
39. Rosenberg O, Shoenfeld N, Zangen A, Kotler M, Dannon PN. 2010. Deep TMS in a resistant major depressive disorder: a brief report. Depress Anxiety 27:465-469.
40. Roth Y, Amir A, Levkovitz Y, Zangen A. 2007. Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils. J Clin Neurophysiol 24:31-38.
41. Szegedi A, Müller MJ, Anghelescu I, Klawe C, Kohnen R, Benkert O. 2003. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. J Clin Psychiatry 64:413-420.
42. Townsend J, Bookheimer SY, Foland-Ross LC, Sugar CA, Altshuler LL. 2010. fMRI abnormalities in dorsolateral prefrontal cortex during a working memory task in manic, euthymic and depressed bipolar subjects. Psychiatry Res 182:22-29.
43. Wassermann EM, Zimmermann T. 2012. Transcranial magnetic brain stimulation: therapeutic promises and scientific gaps. Pharmacol Ther 133:98-107.
44. World Health Organization. 1992. The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization.
45. Ye T, Peng J, Nie B, Gao J, Liu J, Li Y, et al. 2012. Altered functional connectivity of the dorsolateral prefrontal cortex in first-episode patients with major depressive disorder. Eur J Radiol 81:4035-4040.